2-Hydroxy-4-methoxybenzaldehyde CAS 673-22-3

Description:

Nomen chemicum: 2-Hydroxy-4-methoxybenzaldehyde

CAS: 673-22-3

Dic: ≥99.0% (HPLC)

Aspectus: Alba ad Beige pulveris

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Manufacturer Supple cum Quality, Commercial Productio
Nomen chemicum: 2-Hydroxy-4-methoxybenzaldehyde
CAS: 673-22-3

Chemical Properties:

Nomen chemicum 2-Hydroxy-4-methoxybenzaldehyde
Synonyma 2-HMB;2-Hydroxy-p-anisaldehyde;4-Methoxysalicylaldehyde
CAS Number 673-22-3
CATTUS Number RF-PI368
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H8O3
M. Pondus 152.15
Liquescens punctum 41.0~43.0℃ (lit.)
Ferveret 124℃(lit.) at 12 mmHg
Density 1.2143
Solubilitas Solutum in Methanol, insolubile in aqua
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad Pulverem Beige
Asssay / Analysis Methodo ≥99.0% (HPLC)
Humorem (By KF) ≤0.50%
2,4-DihydroxyBenzaldehyde ≤0.50%
2,4-DimethoxyBenzaldehyde ≤0.50%
Ignota impudicitia ≤0.30%
Totalis immunditias ≤1.0%
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Lucem protege, humorem.

commoda:

1

FAQ:

Applicatio:

2-Hydroxy-4-methoxybenzaldehyde (CAS 673-22-3) est medium magni ponderis in synthesi organica et campo pharmaceutico.2-Hydroxy-4-methoxybenzaldehyde adhibetur in synthesi Schiff basi ligandi.Applicatur ut reactant in synthesi LPA1R antagonistae adhibitae in inhibitione LPA inductae multiplicationis et contractionis fibroblastarum humanarum normalium pulmonis.Usus etiam in synthesi tyrosinae kinasi 6 proteinase inhibitores.2-Hydroxy-4-methoxybenzaldehyde, compositum chemicum et isomer Vanillin, adhiberi potuit ad synthesim Urolithin M7.2-hydroxy-4-methoxybenzaldehyde inhibitor tyrosinase potentior est.

Epistulam tuam hic scribe et mitte nobis